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Leptin is involved not only in the regulation of food intake but also in other functions including
reproduction. Because leptin has been demonstrated to influence ovarian steroidogenesis directly and leptin
levels vary during the menstrual cycle and in stimulated cycles, we tested the hypothesis that serum or
intrafollicular concentrations of leptin would correlate with reproductive outcomes in intracytoplasmic
sperm injection cycles. Serum and follicular fluid samples were collected from 77 women undergoing
ovarian stimulation, intracytoplasmic sperm injection and embryo transfer due to male factor infertility.
The concentrations of total leptin, both in serum and in pooled follicular fluid samples, did not correlate
with the number of oocytes, the fertilization rate or the embryo quality. Additionally, leptin concentra-
tions did not differ between cycles that resulted in pregnancy and those that failed. These results raise
objections to the prognostic value of leptin for the outcome of in vitro fertilization/intracytoplasmic sperm
injection cycles.
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INTRODUCTION
Leptin, the 16-kd product of the LEP gene located in
7q31.3, is mainly produced in adipose tissue and is con-
sidered to play an important role in appetite control, fat
metabolism, and consequently in the regulation of body
weight.1,2 The levels of circulating leptin strongly corre-
late with body mass index (BMI).1,2 LEP gene is also
expressed in skeletal muscle, stomach, endometrium, and
placenta whereas its expression in ovarian tissues is still in
doubt.1-3 The effects of leptin are mediated by receptors
on the extracellular membrane with a single trans-
membrane domain. Leptin receptors are encoded by the
LEPR gene found in 1q31 chromosome and belong to
gp130 family receptors. Five leptin receptors have
been described as the result of alternative splicing:
Ob-Ra,Ob-Rb,Ob-Rc,Ob-Rd, and Ob-Re.Ob-Rb is
considered to be the main functional receptor expressed
in hypothalamus and in other sites as well. Ob-Re is a
soluble receptor regulating the bioactivity of leptin. It
seems that at least one isoform of leptin receptors is
expressed in almost every tissue of the human body.1-3
Soon after its discovery, leptin was linked to repro-
ductive functions. It was shown that it participates in the
development of the reproductive system during puberty
as well as in the reproductive functions during adulthood,
acting as a satiety signal that influences the hypothalamus–
pituitary–gonadal axis.1-4 It seems that leptin, by
binding on hypothalamic leptin receptors, modulates the
secretion of gonadotropin-releasing hormone (GnRH)
From the Laboratory of Physiology, School of Medicine, Democritus University
of Thrace, Alexandroupolis, Greece (BA, GT, NN); Department of Gynecology
and Obstetrics, University Clinic of Schleswig-Holstein, Campus Lübeck,
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by hypothalamic neurons, thus influencing the release of
follicle-stimulating hormone (FSH) and luteinizing
hormone (LH) by gonadotrope pituitary cells. Leptin mod-
ulates further the release of FSH and LH by acting on gona-
dotrope cells, which also express functional leptin receptors.
The effects of leptin in ovarian function have gained a
special attention. Several lines of evidence indicate that the
ovary is a target organ for leptin; ovarian granulosa and
theca cells5 as well as the oocytes6 express high-affinity
receptors for leptin. Many studies have indicated that leptin
has modulatory effects on ovarian steroidogenesis while at
the same time sex hormones influence leptin expres-
sion.5,7-10 It is also well documented that leptin levels show
a considerable variation throughout the human menstrual
cycle, with higher levels during the luteal phase.11,12 The
above findings suggest that leptin may both indirectly and
directly influence follicular growth, oocyte development as
well as implantation. This notion along with the knowl-
edge that overweight and obese women have usually a
poor outcome in in vitro fertilization (IVF) cycles13 has
fuelled the investigation on the prognostic value of leptin
for the outcome of IVF cycles.
During the last years, many studies aimed to find an
association between leptin levels either in serum or in fol-
licular fluids (FFs) and the outcome of IVF cycles. How-
ever, these studies have failed to reach consensus.10,14-28
In the present study, the concentrations of leptin in
both blood and FFs were investigated as possible prognos-
tic markers for the outcome in intracytoplasmic sperm
injection (ICSI) cycles. The relationships of leptin
concentrations with those of other hormones were also
investigated. The women who participated in the study
had a normal reproductive system and followed con-
trolled ovarian stimulation (COH), ICSI, and embryo
transfer exclusively due to male factor infertility.
MATERIALS AND METHODS
Participants, COH, ICSI, and Embryo
Transfers
The study was carried out in the Department of Gynecol-
ogy and Obstetrics, University Clinic of Schleswig-
Holstein in Campus Lübeck. The study population
included 77 women without any apparent abnormality
of their reproductive system as defined by their medical
history, the clinical examination, and common hormonal
tests. They participated in ICSI cycles exclusively due to
male factor infertility. Their age was 32.8 + 3.7 years
(range ¼ 22-41). Low responders as well as women with
basal FSH 10 mIU/mL were excluded. The study was
approved by the Internal Review Board. Only 1 cycle
from each patient was included in the study.
Controlled ovarian stimulation was performed
according to the multidose GnRH-antagonist protocol
(‘‘Lübeck antagonist protocol’’) as described else-
where.29,30 Briefly, the pituitary suppression was
achieved with cetrorelix (Cetrotide, Serono International
SA, Geneva, Switzerland) 0.25 mg per day from cycle day
6 onward until ovulation induction. The ovarian stimula-
tion was achieved with recombinant FSH (recFSH;
Gonal-F, Serono International S.A., Geneva, Switzerland),
which was individually adjusted according to serum
estradiol (E2) levels and ovarian sonography. Final oocyte
maturation was induced by injection of 10 000 IU human
chorionic gonadotropin (hCG; Pregnyl; N.V. Organon,
Oss, Holand) when at least 3 follicles reached a diameter
of 17 mm and the serum E2 concentration increased to
300 to 500 pg/mL per follicle. Transvaginal oocyte
aspiration with ultrasound guidance was performed
36 hours later.
The preparation of oocytes, ICSI, and culture of fer-
tilized oocytes were performed as previously described.21
Only fresh semen samples obtained by masturbation after
3 to 4 days of abstinence were used.
Embryo transfers were performed 48 hours after
oocyte aspiration under ultrasound guidance. Up to
3 cleaving embryos were transferred, according to the Ger-
man Embryo Protection Law. Before embryo transfers,
according to the degree of fragmentation and the regular-
ity of blastomeres, each embryo was graded as follows: G1
(very good quality), G2 (good quality), and G3 (bad qual-
ity). Each grade was assigned a value: G1 ¼ 3, G2 ¼ 2,
and G3 ¼ 1. The score for each embryo was the product
of grade value multiplied by the number of blastomeres.
The cumulative embryo score (CES) was the sum of the
embryo scores of the transferred embryos.31
The luteal phase was supported daily with 600 mg
natural progesterone (P) administrated vaginally (Utroge-
stan; Besins-Iscovesco, Paris, France). Pregnancies were
defined by the presence of positive fetal heart beats. In
these cases, the administration of P was continued up to
week 12 of gestation.
Sampling and Measurements
On the day of hCG, peripheral blood samples were taken
from each woman, sera were extracted and aliquots stored
at 75C.
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During oocyte aspiration, FF samples from follicles
containing oocytes were collected in separate tubes.
Follicular fluids contaminated with flushing fluid or with
obvious presence of blood were not collected. After
denudation of oocytes, those tubes which contained fluids
coming from follicles with metaphase II (MII) oocytes
were pooled together whereas others were discarded.
Pooled FFs were mildly centrifuged and the supernatants
were stored at 75C in aliquots for further analysis.
In serum samples, total leptin, E2, P, LH, and testos-
terone, whereas in FF samples, total leptin, E2, and P,
were measured.
In serum samples, E2, P, LH, and testosterone were
measured with Elecsys immunoanalyzer (Roche Diag-
nostics, Mannheim, Germany) having the following
intra-assay and inter-assay variations (AV): <5% and
<10% for E2, <3% and <5% for P, <5% and <7% for
testosterone. All the other measurements were made with
commercially available enzyme immunoassay kits as
follows. E2: DSL-10-4300 Active Estradiol EIA (DSL,
Webster, Tex), intra-AV: 3.3% to 4.8%, inter-AV: 6.5%
to 8.2%, minimum detectable dose (MDD): 7 pg/mL,
P: DE220 (R&D Systems Inc, Minneapolis, Minn),
intra-AV: 4.9% to 7.6%, inter-AV: 2.7% to 8.3%, MDD:
8.57 pg/mL. Leptin: Quantikine DLP00 (R&D Systems
Inc, Minneapolis, Minn), intra-AV: 3% to 3.3%, inter-
AV: 3.5% to 5.4%, and MDD: 7.8 pg/mL.
As the above kits are validated for serum samples but
not for FFs, before running FF samples, we checked the
recovery rate of at least 3 spiked FF samples and the lin-
earity of the results after multiple dilutions. The results
were satisfactory, with recovery rates ranging from 80%
to 130%. All samples were measured twice, according
to manufacturers’ instructions. In cases of very high or
low results, the measurements were repeated with
appropriate dilution.
Statistical Analysis
The cycles that resulted in pregnancy are referred to as
group A and the cycles that failed to result in pregnancy
are referred to as group B. The normality of all studied
parameters was checked with the Shapiro-Wilks’ W test
and an additional evaluation of kurtosis and skewness.
The statistical analysis included descriptive statistics for
both studied groups. The comparisons of clinical data as
well as hormonal and cytokine concentrations between
the groups were performed either with the t test, or with
2 nonparametric tests: Mann-WhitneyU test and
Kolmogorov-Smirnov. Correlations were evaluated with
the Spearman Rank test. The 2-tailed significant level was
set at P < .05. Statistical analysis was performed using the
software STATISTICA 6.0 (StatSoft Inc., Tulsa, Okla).
All values are presented as mean + standard deviation.
RESULTS
Among the 77 cycles, 19 resulted in clinical pregnancies.
There were no cycles with clinical symptoms of ovarian
hyperstimulation syndrome. The clinical characteristics
as well as the measurements of the cycles that resulted
in pregnancy (group A) and those that failed (group B) are
presented in Table 1.
The 2 groups were similar in terms of age, BMI, and
the quality of transferred embryos. Group A received
lower amount of gonadotropins, had a slightly lower
number of retrieved oocytes, and a slightly higher fertili-
zation rate, in comparison to group B, though these dif-
ferences were not statistically significant. Group A had
also lower peak serum E2 concentrations than group B
but not at a statistically significant level.
There were no significant differences between the 2
groups regarding the concentrations of total leptin and the
studied hormones in both serum samples and pooled FFs.
The correlations among the studied parameters are
presented in Tables 2 and 3. The amount of administrated
recFSH showed positive correlations with intrafollicular
P concentrations. Serum and intrafollicular leptin corre-
lated positively and strongly with BMI. The number of
oocytes retrieved, the fertilization rate as well as the CES
did not correlate neither with serum nor with intrafolli-
cular leptin. The number of oocytes retrieved correlated
positively with peak E2 serum and serum P concentra-
tions. The CES of the transferred embryos had a weak
positive correlation with Peak E2 serum concentrations.
Intrafollicular leptin correlated positively with intrafolli-
cular P concentrations.
DISCUSSION
During the last decade, many studies have aimed to explore
the association of leptin levels with the outcome of IVF
cycles in terms of ovarian response to COH, oocyte qual-
ity, embryo quality, and the achievement of pregnancy.
However, their results have been contradictory.
Barroso et al32 reported that leptin FF levels correlate
negatively with embryo quality in IVF cycles, suggesting
that leptin, together with vascular endothelial growth fac-
tor, is a marker of follicular hypoxia. At the same time,
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Bützow et al14 found that a considerable increase in leptin
levels during COH is related with reduced ovarian
response. Later on, similar findings were reported by
other investigators.22,23,26
Mantzoros et al15 were the first who reported that
women who became pregnant during IVF or gamete
intrafallopian transfer (GIFT) cycles had significantly
lower intrafollicular leptin concentrations than women
who failed to become pregnant. After that, several inves-
tigators reported that either serum or intrafollicular high
levels of leptin are associated with lower pregnancy rates
in IVF cycles.10,16,20-23
The present study opposes the notion that circulating
or intrafollicular concentrations of leptin can serve as a
Table 1. Clinical Characteristics, Hormonal and Cytokines Concentrations of the 2 Studied Groupsa
Parameter Group A (n ¼ 19) Group B (n ¼ 58) P
Age 31.7 + 3.6 (29.9-34) 33.2 + 3.8 (32.2-34.2) .914b
BMI 24.9 + 4.6 (22.7-27) 23.7 + 3.9 (22.6-24.7) .272c
recFSH (IU) 1803.9 + 593.4 (1517.9-2090) 2081.1 + 765.9 (1877.9-2284.3) .425c
Number of retrieved MII oocytes 8.7 + 4.5 (6.6-11) 10.1 + 5.2 (8.7-11.4) .512b
Fertilization rate (%) 62 + 20.5 (52.1-72) 55.1 + 25.2 (48.4-61.8) .365c
Number of embryos transferred 2.263 + 0.653 (1.9-3) 2.421 + 0.706 (2.2-2.6) .346c
CES 21.4 + 8.9 (17.1-26) 21.4 + 10.3 (18.7-24.1) .523b
Serum E2 (pg/mL) 1748.9 + 1425.1 (1062.1-2436) 2117.4 + 1035.6 (1837.4-2397.4) .083c
Serum P (ng/mL) 0.8 + 0.3 (0.6-1) 0.9 + 0.4 (0.7-1) .375c
Serum testosterone (ng/mL) 0.6 + 0.5 (0.3-1) 0.5 + 0.2 (0.4-0.6) .675c
Serum LH (ng/mL) 1.9 + 2.3 (0.8-3) 1.8 + 1.6 (1.4-2.3) .767c
Serum leptin (pg/mL) 20903 + 21790.5 (8835.8-32970) 15979.2 + 10174.5 (12885.8-19072.5) .911c
FF-E2 (pg/mL) 834162.6 + 400702.9 (628140.2-1040185) 744213.9 + 414388.1 (632189.1-856238.6) .453c
FF-P (ng/mL) 23553.3 + 5262.2 (17019.4-30087) 20582.5 + 10262.9 (16522.6-24642.4) .22c
FF-leptin (pg/mL) 27700.3 + 23681.6 (15524.3-39876) 24921.1 + 19490 (19601.4-30240.9) .857c
Abbreviations: BMI, body mass index; CES, cumulative embryo score; E2, estradiol; FF, follicular fluid; FSH, follicle-stimulating hormone; hCG,
human chorionic gonadotropin; LH, luteinizing hormone; MII, metaphase II; P, progesterone; recFSH, recombinant FSH.
a Group A: cycles resulted in pregnancy; Group B: cycles that did not result in pregnancy. Serum concentrations were measured at the day of hCG.
The values are given as mean + standard deviation; confidence intervals 95% are given in parenthesis.
b P estimated by t test.
c P estimated by Mann-WhitneyU test.
Table 2. Correlations Among the Clinical Characteristics of the ICSI Cycles and the Serum Concentrations of Hormones and
Cytokines at the Day of hCGa
Serum E2 Serum P Serum Testosterone Serum LH Serum Leptin
Age 0.058 0.136 0.364b 0.172 0.249
BMI 0.179 0.169 0.101 0.061 0.491b
recFSH 0.02 0.04 0.28 0.002 0.077
Number of retrieved MII oocytes 0.497b 0.322b 0.184 0.268b 0.007
Fertilization rate 0.109 0.032 0.079 0.051 0.087
CES 0.291b 0.112 0.075 0.036 0.117
Serum E2 0.572b 0.572b 0.151 0.117
Serum P 0.522b 0.059 0.2
Serum testosterone 0.493b 0.221
Serum LH 0.105
Serum leptin
Abbreviations: BMI, body mass index; CES, cumulative embryo score; E2, estradiol; FF, follicular fluid; FSH, follicle-stimulating hormone; hCG,
human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection; LH, luteinizing hormone; MII, metaphase II; P, progesterone; recFSH,
recombinant FSH.
a Spearman R is given.
b P < .05.
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prognostic factor for the outcome in ICSI cycles. According
to our present results, neither circulating nor intrafollicu-
lar leptin concentrations were associated with the number
of oocytes retrieved, the fertilization rate, the CES, and
the achievement of pregnancy. These results are consis-
tent with several previous studies.17-19,24-27
Indisputably, leptin is mandatory for the normal repro-
ductive function. It acts at multiple levels of the reproduc-
tive axis, and it seems that its effects depend on its
concentrations; high levels of leptin exert inhibitory direct
actions on gonadal functions.3 The hypothalamus–pituitary
axis probably is not influenced by high circulating levels of
leptin because the saturable system of leptin through the
blood–brain barrier prevents excess concentrations of leptin
binding to hypothalamic receptors.33 It is also worth noting
that during COH that precedes IVF and embryo transfer,
the hypothalamus–pituitary axis is carefully controlled and
ceased. Therefore, the actions of leptin on GnRH neurons
and gonadotrope cells are probably meaningless, whereas its
direct actions on ovarian cells might be considerable.
Regarding the direct actions on ovarian cells, a large
body of evidence indicates that leptin at high concentrations
antagonizes the augmenting effect of several growth factors
and hormones on gonadotropin-stimulated steroidogenesis
in both ovarian theca and granulosa cells, whereas low
concentrations of leptin either do not influence or even sti-
mulate the aromatase activity of granulosa cells.5,7-10
The question is which are the critical levels of leptin
to affect the ovarian functions? In other words, which
levels are ‘‘high’’ and which levels are ‘‘low’’?
In this respect, the selection of the study population
might have influenced the results to a large extent as the
expression of leptin may be influenced by factors as BMI
and inflammatory conditions. This study included
healthy, nonobese women who participated in ICSI
cycles exclusively due to male factor infertility.
Moreover, the methodology of measurements also
has an impact on the results. Different methods of mea-
suring leptin concentrations in blood and FFs have been
used in each published study. However, not all assays
have comparable sensitivity or specificity. It is well
known that measuring a cytokine in the same sample by
different assays can bring about different results. This is
more obvious in FF samples because not all assays are vali-
dated for this kind of samples. This methological problem
obscures the definition of the ‘‘high’’ and ‘‘low’’ concen-
trations of leptin. By measuring the same samples with
different assay kits, different ‘‘high’’ and ‘‘low’’ concen-
trations of leptin may arise.
Last but not least, not all the studies have followed the
same methodology of FFs collection. A number of studies
have measured leptin concentrations in individual follicles
whereas others in pooled FFs. The first method is very use-
ful when the main aim is to investigate the maturation sta-
tus and the fertilization potential of individual oocytes as
well as the development of the embryos that come from
these oocytes. Pooled FFs are used to negate the variation
in leptin concentrations in individual follicles as well as to
be consistent with ‘‘pooled embryo transfers,’’ thus mea-
surements in pooled FFs are supposed to be more reliable
when the main aim is to investigate the ovarian response
(in terms of the total number of MII oocytes retrieved), the
CES of transferred embryos, and the pregnancy outcome.
It is obvious that the concentrations of leptin might be very
different according to the method of FF collection used.
Furthermore, it is not always clearly stated from what
kind of follicles the fluids are coming from. Mature folli-
cles containing MII oocytes have a different cytokine and
hormonal profile than small follicles. We believe that FFs
derived from follicles of different status of maturation give
confusing and unreliable results. In this study, we mea-
sured leptin and hormone levels in pooled FFs coming
from mature follicles containing MII oocytes.
For all the above reasons, the comparison of the
results from different studies exploring the role of leptin
on the outcome of IVF cycles is not always easy and the
evaluation of the prognostic value of leptin levels
becomes difficult. The results and conclusions of the
relevant studies, including the present one, have to be
considered only as indicative.
Table 3. Correlations Among the Clinical Characteristics of
the Studied ICSI Cycles and the Concentrations of Hormones
and Cytokines in Follicular Fluid Samplesa
FF-E2 FF-P FF-Leptin
Age 0.16 0.066 0.3b
BMI 0.078 0.482b 0.584b
recFSH 0.012 0.402b 0.058
Number of retrieved MII oocytes 0.181 0.027 0.027
Fertilization rate 0.141 0.021 0.019




Abbreviations: BMI, body mass index; CES, cumulative embryo
score; E2, estradiol; FF, follicular fluid; FSH, follicle-stimulating
hormone; ICSI, intracytoplasmic sperm injection; MII, metaphase II;
P, progesterone; recFSH, recombinant FSH.
a Spearman R is given.
b P < .05.
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In our opinion, although high levels of leptin seem to
disrupt the function of ovarian cells and compromise the
quality and the fertilizability of the oocytes, the usefulness
of leptin concentrations, either circulating or intrafollicu-
lar, as a prognostic marker for the outcome in IVF/ICSI
cycles is not granted. It is not certain that leptin levels can
always predict the fertilization outcome, the embryo
development, or the pregnancy outcome in IVF/ICSI
cycles. Furthermore, because follicular maturation, ferti-
lization, and implantation are complex processes where
a plethora of factors play a role, we can postulate that it
is rather impossible for one of them, namely leptin, to
be established as a reliable prognostic factor.
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